Your browser doesn't support javascript.
loading
Proteomic analysis of Caco-2 cells treated with monacolin K.
Lin, Wun-Yuan; Song, Ching-Yung; Pan, Tzu-Ming.
Afiliação
  • Lin WY; Department of Food Science, Nutrition and Nutraceutical Biotechnology, Shih Chien University, Taipei, Taiwan, Republic of China.
J Agric Food Chem ; 54(17): 6192-200, 2006 Aug 23.
Article em En | MEDLINE | ID: mdl-16910707
Monascus species is an important traditional fermentation fungus used on food. Monacolin K (a secondary metabolite of Monascus, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase) in inhibition of mevalonate synthesis may result in reductions of isoprenoid prenylation in cells. Impairment of protein isoprenoid prenylation has been related to anticancer effect in cancer cells. As a functional food for Monascus, however, the molecular mechanisms responsible for the anti-proliferate effect of monacolin K in cancer cells are not clear. We used proteomic analysis by two-dimensional gel electrophoresis, matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS), tandem mass spectrometry (MS/MS), and database interrogation to separate and identify the proteins of Caco-2 cells treated with monacolin K. The results showed that monacolin K inhibited the proliferation of Caco-2 cells in a dose-dependent manner. The identified proteins in proteomic analysis included anti-oxidation enzymes related to reactive oxygen species stress, cytoskeleton proteins, glycolytic enzymes, and enzymes involved in mediating protein interactions. Furthermore, glutathione S-transferase P 1 and cytoskeleton-8, -18, and -19 revealed a down-regulation in a dose-dependent manner in exposure of Caco-2 cells to monacolin K.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Lovastatina / Neoplasias do Colo / Proteômica / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2006 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Lovastatina / Neoplasias do Colo / Proteômica / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2006 Tipo de documento: Article